<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02495220</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00008711068</org_study_id>
    <nct_id>NCT02495220</nct_id>
  </id_info>
  <brief_title>Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery</brief_title>
  <official_title>Subtenon Versus Intravenous Dexmedetomidine for Postoperative Analgesia and Vomiting Control in Infantile Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study was to evaluate the efficacy and safety of subtenon block
      (SB)anesthesia with dexmedetomidine in combination with bupivacaine versus intravenous
      dexmedetomidine for postoperative analgesia and emesis control in infants undergoing cataract
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, randomized, controlled, double blind trial eighty ASA physical status
      grade I and II infants (1-12month) undergoing elective cataract surgery in one eye under
      general anesthesia were studied. Infants were randomly allocated to one of the two groups:
      subtenon block Group (SB) with dexmedetomidine (n =40) or intravenous dexmedetomidine Group
      (IV) (n =40). After securing the airway, infants in Group (SB) received SB block with 0.05
      mL/kg of 0.5%bupivacaine and 0.5µ/kg dexmedetomidine mixture, whereas infants in Group (IV)
      received 1µ/kg IV dexmedetomidine after induction of anesthesia. Surgery started after 5 min
      of study drug administration. Postoperative assessment for number of infants requiring rescue
      analgesia and rescue antiemetics was the primary outcome. CRIES pain scale score , vomiting
      scale score during4-h study period, incidence of oculocardiac reflex and any surgical
      difficulty were the Secondary outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative assessment for number of infants requiring rescue analgesia and rescue antiemetics</measure>
    <time_frame>4 hours postoperatively</time_frame>
    <description>by analysis for number of infants withCRIES pain scale score &gt;3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative CRIES pain scale score</measure>
    <time_frame>4 hours postoperatively</time_frame>
    <description>(0-2 for each parameter)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vomiting scale score</measure>
    <time_frame>4 hours postoperative</time_frame>
    <description>a numeric rank score, where 0= no vomiting 1=vomited once and 2=vomited twice or more</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of oculocardiac reflex(OCR)events(acute reduction in heart rate of &gt;20%).</measure>
    <time_frame>intraoperative period</time_frame>
    <description>by analysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Vomiting</condition>
  <arm_group>
    <arm_group_label>subtenon block Group (SB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>received SB block with 0.05 mL/kg of 0.5%bupivacaine and 0.5µ/kg dexmedetomidine mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous dexmedetomidine Group(IV)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>received 1µ/kg IV dexmedetomidine after induction of anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SB dexmedetomidine bupivacaine block</intervention_name>
    <description>SB block with 0.05 mL/kg of 0.5%bupivacaine and 0.5µ/kg dexmedetomidine mixture</description>
    <arm_group_label>subtenon block Group (SB)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous dexmedetomidine</intervention_name>
    <description>received 1µ/kg IV dexmedetomidine</description>
    <arm_group_label>intravenous dexmedetomidine Group(IV)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA physical status grade I and II infants (1-12month).

          2. undergoing elective cataract surgery in one eye under general anesthesia.

        Exclusion Criteria:

          1. infection of the orbit,

          2. increased intraocular pressure(IOP),

          3. history of allergy to local anesthetics,

          4. history of previous eye surgery,

          5. cardiovascular or clotting disorders,

          6. full stomach,inner ear disorders or other conditions predisposing to vomiting

          7. airway abnormalities

          8. compromised sclera.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>jehan A sayed, MD</last_name>
    <phone>+2 01006253939</phone>
    <email>jehan.alloul@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut Univeristy Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jehan A Sayed, MD</last_name>
      <phone>+2 01006253939</phone>
      <email>jehan.alloul@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Mohamed Amir F Riad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>jehan A Sayed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2015</study_first_submitted>
  <study_first_submitted_qc>July 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2015</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>jehan ahmed sayed</investigator_full_name>
    <investigator_title>assistant professor in anesthesia and intensive care department,faculty of medicine assiut university</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>subtenon anesthesia</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>pov</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

